315 related articles for article (PubMed ID: 15928737)
1. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Swiatecka G
Kardiol Pol; 2005 Apr; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
[TBL] [Abstract][Full Text] [Related]
2. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
[TBL] [Abstract][Full Text] [Related]
3. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
[TBL] [Abstract][Full Text] [Related]
4. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
[TBL] [Abstract][Full Text] [Related]
5. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
[TBL] [Abstract][Full Text] [Related]
6. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
7. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
[TBL] [Abstract][Full Text] [Related]
9. Predictors of sinus rhythm return during defibrillation testing in patients with permanent atrial fibrillation undergoing implantation of a cardioverter-defibrillator.
Lelakowski J; Tomala I; Cmiel A; Rydlewska A; Majewski J; Małecka B
Kardiol Pol; 2011; 69(1):17-22. PubMed ID: 21267958
[TBL] [Abstract][Full Text] [Related]
10. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
[TBL] [Abstract][Full Text] [Related]
11. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
[TBL] [Abstract][Full Text] [Related]
12. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with relatively high effective defibrillation threshold during cardioverter defibrillator implantation with endocardial leads.
Rosenheck S; Sharon Z; Weiss A
Cardiology; 2009; 112(2):107-13. PubMed ID: 18583908
[TBL] [Abstract][Full Text] [Related]
15. Predictors of successful defibrillation threshold test during CRT-D implantation.
Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
[TBL] [Abstract][Full Text] [Related]
16. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
[TBL] [Abstract][Full Text] [Related]
17. Is haemodynamic evaluation with impedance cardiography in patients with heart failure undergoing testing of the implanted cardioverter-defibrillator of clinical importance?
Krzesiński P; Michałkiewicz D; Orski Z; Krzyżanowski K; Gielerak G
Kardiol Pol; 2011; 69(6):548-56. PubMed ID: 21678288
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of nonthoracotomy cardioversion-defibrillation system.
Hua W; Vohra J; Mond H
Chin Med J (Engl); 1998 Jul; 111(7):648-51. PubMed ID: 11245056
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors.
Dułak E; Lubiński A; Bissinger A; Przybylski A; Sterlinski M; Filipecki A; Pazdyga A; Zienciuk A; Kempa M; Królak T; Szwed H; Trusz-Gluza M; Kargul W
Kardiol Pol; 2009 Aug; 67(8):837-44. PubMed ID: 19784881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]